Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kristina Lamberg, Lundström"'
Autor:
Pernilla Sönnerfors, Petra Kristina Jacobson, Anders Andersson, Annelie Behndig, Leif Bjermer, Anders Blomberg, Heléne Blomqvist, Jonas Erjefält, Maria Friberg, Kristina Lamberg Lundström, Anna Lundborg, Andrei Malinovschi, Hans Lennart Persson, Ellen Tufvesson, Åsa Wheelock, Christer Janson, Carl Magnus Sköld
Publikováno v:
European Clinical Respiratory Journal, Vol 11, Iss 1 (2024)
Background A substantial proportion of individuals with COPD have never smoked, and it is implied to be more common than previously anticipated but poorly studied.Aim To describe the process of recruitment of never-smokers with COPD from a population
Externí odkaz:
https://doaj.org/article/fc7f254c9fee459793125ad93be3f540
Publikováno v:
Upsala Journal of Medical Sciences, Vol 122, Iss 1, Pp 56-60 (2017)
Background: Patients treated for hematological malignancies have an increased risk of serious infections. Diagnosis and prompt initiation of therapy are essential. Bronchoalveolar lavage (BAL) is a well-established investigation for identifying the c
Externí odkaz:
https://doaj.org/article/61cf76b85e5841b78e32f9d32b537107
Autor:
Andrea Lindgren, Erik Holmberg, Lars Ek, Kristina Lamberg Lundström, Patrick Micke, Johanna Sofia Margareta Mattsson, Miklos Gulyas, Bengt Bergman, Annelie F. Behndig
Publikováno v:
Acta Oncologica. 57:244-250
Aim: Inhibition of cyclooxygenase-2 (COX-2) is proposed as a treatment option in several cancer types. However, in non-small cell lung cancer (NSCLC), phase III trials have failed to demonstrate a benefit of adding COX-2 inhibitors to standard chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10adc94230f48d769607dbc69c8bc219
https://doi.org/10.1080/0284186x.2017.1400685
https://doi.org/10.1080/0284186x.2017.1400685
Publikováno v:
Upsala Journal of Medical Sciences
Upsala Journal of Medical Sciences, Vol 122, Iss 1, Pp 56-60 (2017)
Upsala Journal of Medical Sciences, Vol 122, Iss 1, Pp 56-60 (2017)
BACKGROUND: Patients treated for hematological malignancies have an increased risk of serious infections. Diagnosis and prompt initiation of therapy are essential. Bronchoalveolar lavage (BAL) is a well-established investigation for identifying the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a9b4faaa002791b09c3a5abac71d41
https://pubmed.ncbi.nlm.nih.gov/27739337
https://pubmed.ncbi.nlm.nih.gov/27739337
Autor:
Signe Friesland, Martin Helsing, Kristina Lamberg Lundström, Margareta Holgersson, Elisabet Birath, Simon Ekman, Charlotte Mörth, Christer Janson, Even Hoye, Roger Henriksson, Thomas Blystad, Britta Lödén, Michael Bergqvist, Georg Holgersson, Jan Nyman, Stefan Bergström, Martin Sandelin, Sven-Börje Ewers
Publikováno v:
Medical Oncology. 29:3176-3182
There is a need to improve the prognostic and predictive indicators in non-small cell lung cancer (NSCLC). At present, the main focus is on genetic predictive markers while the prognostic value of the standard blood variables related to haematopoiesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::281e46325327901066e1b2268043d7b2
https://doi.org/10.1007/s12032-012-0247-3
https://doi.org/10.1007/s12032-012-0247-3
Autor:
Michael Bergqvist, Georg Holgersson, Johan Harmenberg, Simon Ekman, Hirsh Koyi, Stefan Bergström, Magnus Ringbom, Kristina Lamberg Lundström, Eva Brandén, Olle Larsson, Markus Jerling, Maria Klockare
Publikováno v:
Medical Oncology. 32
AXL1717 is an orally bioavailable IGF-1R pathway modulator that has been shown to have anti-tumoral effects. The objectives of the present study were to define maximum tolerated dose and the recommended phase II dose (RPTD) of AXL1717 in combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dbab1096950db959d564dd701a8df6
https://doi.org/10.1007/s12032-015-0578-y
https://doi.org/10.1007/s12032-015-0578-y
Autor:
Georg, Holgersson, Martin, Sandelin, Even, Hoye, Stefan, Bergström, Roger, Henriksson, Simon, Ekman, Jan, Nyman, Martin, Helsing, Signe, Friesland, Ola, Brodin, Margareta, Holgersson, Kristina Lamberg, Lundström, Christer, Janson, Lars, Ekberg, Charlotte, Mörth, Thomas, Blystad, Sven-Börje, Ewers, Britta, Löden, Michael, Bergqvist
Publikováno v:
Anticancer research. 32(4)
The aim of the present study was to retrospectively investigate the impact of induction chemotherapy on treatment outcome in patients treated with curatively intended radiotherapy for non-small cell lung cancer (NSCLC).Patients with a diagnosed NSCLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::204e8375b494d54fd1a30959c0e84617
https://pubmed.ncbi.nlm.nih.gov/22493368
https://pubmed.ncbi.nlm.nih.gov/22493368